Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Scopia Capital Has Almost 10% of PHH Corp

Page 1 of 2

Scopia Capital now owns 5.7 million shares of PHH Corporation (NYSE:PHH), which according to a filing with the SEC gives it almost 10% of the total shares outstanding. The fund had owned 5 million shares at the end of September, according to its 13F filing (see more stocks Scopia owned), so overall Scopia has added shares in the last three and a half months. PHH is a credit services company with three business segments: mortgage production, mortgage servicing, and vehicle leasing and fleet management services. Matt Sirovich and Jeremy Mindich co-founded Scopia in 2001 and the fund reported over $2 billion in assets under management in early 2012.

For the most part, revenue from PHH’s various sources was about flat in the third quarter of 2012 compared to the same period in the previous year. The company did have a sizable gain on mortgage loans, a business which is responsible for about 40% of revenue, but most of the increase in net revenue was due to lower net loan servicing losses. Expenses swelled slightly, with the result that overall PHH had a net loss of $42 million. This was a 72% decline in losses from a year earlier, but still represented EPS of negative 74 cents. In the first nine months of 2012, the company lost 42 cents per share.

The stock price has more than doubled in the last year as the market generally expects PHH Corporation to improve its financials. Wall Street analysts are even more optimistic, with their earnings expectations for 2013 implying a current-year P/E multiple of only 8. We’d also note that the P/B ratio is 0.9, so the stock is trading at a small discount to the book value of its equity (though, of course, it is currently doing a poor job of monetizing those assets). There is a considerable amount of bearishness in the market, with the most recent data showing that 27% of shares outstanding are held short. Our database of insider trading filings shows one insider buying the stock last August, though those buys came at a significantly lower price than where PHH currently trades (research insider purchases at PHH).


Allan Fournier’s Pennant Capital Management reported owning 5.1 million shares of PHH Corporation at the end of September, and this position was worth over $100 million at that time (check out Fournier’s stock picks). PHH was also one of the ten largest holdings in Fine Capital Partners’ portfolio; that fund is managed by Debra Fine (find more of Fine’s favorite stocks).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!